16-2018 when we expect the readout of the required randomized control study (part of the PMRs) assessing the long-term safety of Iclusig treatment Ariad Pharmaceuticals is a biopharmaceutical company based in Cambric*, Massachusetts The company focuses Its research, development. and commercial efforts on the oncolog